ALK and non-small cell lung carcinoma: One recent study reported that F-circEA1, a fused circular RNA derived from an EML4-ALK1, promoted tumor proliferation, migration, invasion, and cell cycle progression, as well as crizotinib resistance in NSCLC cells.